Clinical Trials in Phoenix

Showing 10401-10420 of 16,646 trials

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

NCT03578432

This early phase 1 trial studies the use of everolimus in restoring salivary gland function in participants with locally advanced head and neck cancer after concurrent chemoradiation or radiation therapy alone.

Salivary Gland DysfunctionXerostomiaHead and Neck Cancer

University of Arizona2 participantsStarted May 2018

Phoenix, Arizona, United States

COMPLETEDPhase 39.8 miles

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

NCT02065791

The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect in reducing the progression of renal impairment relative to placebo in participants with type 2 diabetes mellitus (T2DM), Stage 2 or 3 chronic kidney disease (CKD) and macroalbuminuria, who are receiving standard of care including a maximum tolerated labeled daily dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB).

Diabetes Mellitus, Type 2Diabetic Nephropathy

Janssen Research & Development, LLC4,401 participantsStarted Feb 2014

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tempe, Arizona, United States +572 more locations

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Find Trials by Condition in Phoenix

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

ImageReady(TM) MR Conditional Pacing System Clinical Study

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

HW006 LATERAL Thoracotomy

Post Market Surveillance Study of the Wingspan Stent System

EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media

Safety and Efficacy of PRP for Treatment of Disc Pain

Design Validation of Senofilcon A With New UV-blocking Additive

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

A Clinical Trial of IntensiVE Dialysis